WILMINGTON, Mass. (AP) _ Charles River Laboratories International Inc. (CRL) on Tuesday reported fourth-quarter profit of $44.7 million.
On a per-share basis, the Wilmington, Massachusetts-based company said it had profit of 93 cents. Earnings, adjusted for non-recurring costs and to account for discontinued operations, were $1.21 per share.
The results surpassed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.11 per share.
The medical research equipment and services provider posted revenue of $466.8 million in the period, also beating Street forecasts. Nine analysts surveyed by Zacks expected $442.5 million.
For the year, the company reported profit of $154.8 million, or $3.23 per share. Revenue was reported as $1.68 billion.
Charles River expects full-year earnings in the range of $5 to $5.10 per share.
Charles River shares have climbed 8 percent since the beginning of the year. The stock has climbed 16 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRL at https://www.zacks.com/ap/CRL
Keywords: Charles River Laboratories, Earnings Report